Calithera Biosciences, Inc. (CALA) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Calicera Biosciences 2 Q21 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. And to ask a question during that time, you will need to press star 1 on your telephone keypad. If you require further assistance, please press star 0. I would like to hand the conference over to your speaker for today, Stephanie Wong. Please go ahead. Thank you, operator. Good afternoon, everyone. Welcome to our second quarter 2021 conference call. Joining me today are Susan Molyneux, founder, president, and CEO, and Keith Orford, chief medical officer. Earlier this afternoon, we issued a press release which included an overview of our second quarter 2021 financial and operational results, which can be accessed through our website at calathera.com. Before we begin, I would like to remind you that today's discussion will include statements about our future expectations, plans, and prospects, that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Legation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factor section of our periodic filings with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our views change. Please note that this call is being recorded. And...